Primary protocol
Authorized generic liraglutide
- Identical molecule to brand Saxenda and Victoza
- Manufactured by Teva Pharmaceuticals
- Daily subcutaneous injection
- Average 8% body-weight reduction in clinical trials
- Direct-to-patient cold-chain shipping
